Is intestinal Behçet's disease in fact an enterocolitis or an ulcer disease, and is steroid treatment useful or harmful? [2]

Journal of Gastroenterology

Volumn 38, Issue 10, 2003, Pages 1015-1016

  Takada, Yoshihiko ^a   Saigenji, Katsunori ^b  

^a Takada Ichooka Naika Clinic   (Japan)

^b KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIULCER AGENT; C REACTIVE PROTEIN; COLCHICINE; HISTAMINE H2 RECEPTOR ANTAGONIST; PREDNISOLONE; PROTON PUMP INHIBITOR; STEROID;

BEHCET DISEASE; CLINICAL FEATURE; CROHN DISEASE; DIET THERAPY; DIFFERENTIAL DIAGNOSIS; DISEASE EXACERBATION; DRUG EFFICACY; ENTEROCOLITIS; ENTEROPATHY; ERYTHEMA NODOSUM; FEVER; HISTOPATHOLOGY; HUMAN; INTESTINE ENDOSCOPY; INTESTINE ULCER; LETTER; PEYER PATCH; PRIORITY JOURNAL; STEROID THERAPY; STOMACH ULCER; STOMATITIS; SYMPTOMATOLOGY; TREATMENT PLANNING; ULCER HEALING; ULCERATIVE COLITIS;

ANTI-INFLAMMATORY AGENTS; BEHCET SYNDROME; COLITIS, ULCERATIVE; DIAGNOSIS, DIFFERENTIAL; ENTEROCOLITIS; GLUCOCORTICOIDS; HUMANS; INTESTINAL DISEASES; PREDNISOLONE;

EID: 0344825240     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00535-003-1214-8     Document Type: Letter

References (3)

1. Toda K, Shiratori Y, Yasuda M, Enya M, Uematsu T, Shimazaki M, et al. Therapeutic effect of intraarterial prednisolone injection in severe intestinal Behçet's disease. J Gastroenterol 2002;37:844-8.
2. Takada Y, Fujita Y, Igarashi M, Katsumata T, Okabe H, Saigenji K, et al. Intestinal Behçet's disease-pathognomonic changes in intramucosal lymphoid tissues and effect of a "rest cure" on intestinal lesions. J Gastroenterol 1997;32:598-604.
3. Takada Y. Clinico-pathological study of intestinal Behçet's disease: a review of seven patients and newly proposed theory explaining the development of intestinal ulcerations (in Japanese with English abstract). Kitasato Medicine 1978;8:363-79.